Emerald Mutual Fund Advisers Trust Reata Pharmaceuticals Inc Transaction History

Emerald Mutual Fund Advisers Trust

$1.77 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$79.22 - $105.37 $29,232 - $38,881	369 Added 0.14%	255,387 $26 Million
Q1 2023 May 04, 2023	SELL	$30.85 - $93.17 $8.37 Million - $25.3 Million	-271,427 Reduced 51.56%	255,018 $23.2 Million
Q4 2022 Feb 03, 2023	BUY	$22.15 - $42.11 $1.9 Million - $3.61 Million	85,727 Added 19.45%	526,445 $20 Million
Q3 2022 Oct 25, 2022	BUY	$19.41 - $36.49 $3.68 Million - $6.91 Million	189,450 Added 75.4%	440,718 $11.1 Million
Q2 2022 Jul 29, 2022	BUY	$20.71 - $36.5 $688,856 - $1.21 Million	33,262 Added 15.26%	251,268 $7.64 Million
Q1 2022 Apr 29, 2022	BUY	$24.12 - $39.6 $1.05 Million - $1.73 Million	43,690 Added 25.06%	218,006 $7.14 Million
Q4 2021 Feb 02, 2022	SELL	$25.61 - $110.96 $2.73 Million - $11.8 Million	-106,500 Reduced 37.93%	174,316 $4.6 Million
Q3 2021 Oct 28, 2021	BUY	$100.0 - $143.02 $2.83 Million - $4.05 Million	28,340 Added 11.22%	280,816 $28.3 Million
Q2 2021 Jul 29, 2021	BUY	$78.27 - $151.29 $76,626 - $148,112	979 Added 0.39%	252,476 $35.7 Million
Q1 2021 Apr 29, 2021	BUY	$94.25 - $132.81 $23.7 Million - $33.4 Million	251,497 New	251,497 $25.1 Million
Q3 2020 Oct 28, 2020	SELL	$93.53 - $163.34 $5.39 Million - $9.41 Million	-57,635 Closed	0 $0
Q2 2020 Jul 28, 2020	SELL	$126.3 - $176.56 $5.27 Million - $7.37 Million	-41,739 Reduced 42.0%	57,635 $8.99 Million
Q1 2020 Apr 30, 2020	BUY	$124.16 - $247.74 $194,931 - $388,951	1,570 Added 1.61%	99,374 $14.3 Million
Q4 2019 Jan 29, 2020	SELL	$74.57 - $217.92 $12.6 Million - $36.9 Million	-169,517 Reduced 63.41%	97,804 $20 Million
Q3 2019 Oct 31, 2019	SELL	$71.26 - $95.75 $6.6 Million - $8.87 Million	-92,649 Reduced 25.74%	267,321 $21.5 Million
Q1 2019 May 01, 2019	SELL	$51.9 - $101.79 $6.55 Million - $12.8 Million	-126,240 Reduced 25.96%	359,970 $30.8 Million
Q4 2018 Jan 31, 2019	BUY	$48.76 - $76.44 $2.03 Million - $3.19 Million	41,718 Added 9.39%	486,210 $27.3 Million
Q3 2018 Oct 31, 2018	SELL	$35.64 - $92.06 $1.51 Million - $3.89 Million	-42,249 Reduced 8.68%	444,492 $36.3 Million
Q2 2018 Jul 31, 2018	BUY	$19.94 - $40.96 $311,602 - $640,081	15,627 Added 3.32%	486,741 $17 Million
Q1 2018 Apr 26, 2018	BUY	$20.0 - $30.19 $238,600 - $360,166	11,930 Added 2.6%	471,114 $9.66 Million
Q4 2017 Feb 06, 2018	SELL	$22.39 - $33.27 $310,482 - $461,355	-13,867 Reduced 2.93%	459,184 $13 Million
Q3 2017 Oct 30, 2017	BUY	$26.29 - $31.88 $12.4 Million - $15.1 Million	473,051	473,051 $14.7 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account